Journal: bioRxiv
Article Title: Ductal pancreatic cancer interception by FGFR2 abrogation
doi: 10.1101/2024.10.16.618726
Figure Lengend Snippet: A. Left, representative IF for the acinar marker AMY (white), the ductal marker Dolichos Biflorus Agglutinin (DBA) (green), FGFR2 (red) and 4′,6-diamidino-2-phenylindole (DAPI, blue) conducted on healthy pancreata from B6J mice (n = 5) and ADM and mPanINs from KC mice (n = 6). Scale bars, 25 μm. Right, quantification of staining plotted as mean ± SD. 3 images per mouse were quantified. Unpaired Student’s t test. B. Left, representative IF for CK19 (white), FGFR2 (red) and DAPI (blue) conducted on mPanINs from KC mice (n = 7). Scale bars, 25 μm. Right, quantification of staining plotted as mean ± SD. 3 images per mouse were quantified. C. Left, representative IF for CK19 (white), p53 (green), FGFR2 (red) and DAPI (blue) conducted on tumors from KPC mice (n = 6). Scale bars, 25 μm. Right, quantification of staining plotted as mean ± SD. 3 images per mouse were quantified. Unpaired Student’s t test. D. Representative IHC for FGFR2 conducted on human IPMN and PanIN lesions. E. Left, representative IF for FGFR2 (red), GATA6 (white), S100A2 (green) and DAPI (blue) conducted on human PDAs. Scale bars, 25 μm. Samples that present % GATA6 + S100A2 - cancerous cells > 60 are classified as ‘Classical’, samples with % GATA6 - S100A2 + cancerous cells > 30 are classified as ‘Basal-like’ and samples with % GATA6 + S100A2 + cancerous cells > 5 are classified as ‘IC’. Remaining samples that don’t meet these criteria are classified as ‘other’. Right, quantification of staining plotted as mean ± SD. Unpaired Student’s t test. F. Schematic representation of FGFR2 expression during pancreatic cancer progression in the KRAS G12D -driven mouse model and in human samples.
Article Snippet: To perform IHC, endogenous peroxidase activity was quenched in 3% H 2 O 2 for 20 min. Tissues were blocked in 2.5% Normal Horse Serum blocking solution (Vector Laboratories) for IHC or 5% BSA (Sigma) in TBST buffer for IF and subjected to staining with the following antibodies overnight at 4C: p53 (Leica, P53-CM5P-L 1:100), GFP/YFP (Abcam, ab6673 1:100), AMYLASE (Sigma, A8273 1:250), Dolichos Biflorus Agglutinin (DBA) Fluorescein (VectorLabs, FL-1031 1:200), FGFR2 (Abcam, ab58201 1:1000), CK19 Alexa Fluor 647 (Abcam, ab205446 clone EPR1579Y 1:500), CK19 (Sigma, MABT913 1:500), GATA6 (R&D, AF1700 1:500), S100A2 (Abcam, ab109494 1:250), FGF7 (Origene, TA321423 1:100), FGF10 (Sigma, ABN44 1:100), phospho-p44/42 MAPK (ERK1/2) (Thr202/Tyr204) (CST, 4370 clone D13.14.4E 1:250), Ki67 (ThermoFisher, 14-5698-82 clone SolA15 1:500), Ki67 Alexa Fluor 488 (Abcam, ab281847 clone SP6 1:500), clusterin (ThermoFisher, PA5-46931 1:100).
Techniques: Marker, Staining, Expressing